132836-42-1
中文名称
1,2,3,4-四氢-1-(1-萘基甲基)-6,7-异喹啉二醇氢溴酸盐
英文名称
YS 49
CAS
132836-42-1
分子式
C20H20BrNO2
分子量
386.282
MOL 文件
132836-42-1.mol
更新日期
2024/12/03 15:40:38

基本信息
中文别名
1,2,3,4-四氢-1-(1-萘基甲基)-6,7-异喹啉二醇氢溴酸盐 英文别名
YS 49CS-884
YS 49
YS49
1,2,3,4-Tetrahydro-1-(1-naphthalenylmethyl)-6,7-isoquinolinediol hydrobromide
1,2,3,4-Tetrahydro-1-(1-naphthalenylmethyl)-6,7-Isoquinolinediol hydrobromide monohydrate
所属类别
生物化工:激动剂抑制剂1,2,3,4-四氢-1-(1-萘基甲基)-6,7-异喹啉二醇氢溴酸盐价格(试剂级)
报价日期 | 产品编号 | 产品名称 | CAS号 | 包装 | 价格 |
2025/02/08 | HY-15477 | 1,2,3,4-四氢-1-(1-萘基甲基)-6,7-异喹啉二醇氢溴酸盐 YS-49 | 132836-42-1 | 1 mg | 348元 |
2025/02/08 | HY-15477 | 1,2,3,4-四氢-1-(1-萘基甲基)-6,7-异喹啉二醇氢溴酸盐 YS-49 | 132836-42-1 | 5 mg | 767元 |
2025/02/08 | HY-15477 | 1,2,3,4-四氢-1-(1-萘基甲基)-6,7-异喹啉二醇氢溴酸盐 YS-49 | 132836-42-1 | 10 mg | 1228元 |
常见问题列表
生物活性
YS-49 是 PI3K/Akt (RhoA 的下游靶标) 的激活剂,可减少 3-甲基胆碱处理的细胞中 RhoA/PTEN 的激活。YS-49 能通过诱导血红素加氧酶 (HO-1) 来抑制血管紧张素 II (Ang II) 刺激 VSMC 细胞的增殖。YS-49 是异喹啉化合物生物碱,因能激活心脏 β-adrenoceptors 而具有强烈的正性肌力作用。体外研究
YS-49 (1-100 μM; 18 hours; RAVSMC and RAW 264.7 cells) concentration-dependently inhibits the accumulation of nitrite in both RAVSMC and RAW 264.7 exposed to lipopolysaccharide (LPS) plus INF-γ, with
IC
50
values of 22 μM and 30 μM, respectively.
YS-49 (10-100 μM; 18 hours; RAVSMC and RAW 264.7 cells) suppresses iNOS gene expression induced by LPS and/or cytokines in RAVSMC and RAW 264.7 cells at the transcriptional level.
Cell Viability Assay
Cell Line: | RAVSMC and RAW 264.7 cells |
Concentration: | 10 μΜ, 30 μΜ and 100 μΜ (RAVSMC cells); 1 μΜ, 10 μΜ and 100 μM (RAW 264.7 cells) |
Incubation Time: | 18 hours |
Result: | Inhibited the accumulation of nitrite in both RAVSMC and RAW 264.7 exposed to LPS+INF-γ, with IC 50 values of 22 and 30 μM, respectively. |
Western Blot Analysis
Cell Line: | RAVSMC and RAW 264.7 cells |
Concentration: | 10 μΜ, 30 μΜ and 100 μΜ |
Incubation Time: | 18 hours |
Result: | Concentration-dependently inhibited the expression of iNOS protein induced by LPS plus IFN-γ. |
体内研究
YS-49 (5 mg/kg; intraperitoneal injection; 8 hours; male Sprague Dawley rats) treatment significantly reduces serum NOx levels in LPS-treated rats, the NOx levels reduce from 86 μM to 34 μM.
Animal Model: | Male Sprague Dawley rats (250-300 g) |
Dosage: | 5 mg/kg |
Administration: | Intraperitoneal injection; 8 hours |
Result: | Serum NOx levels were significantly reduced. |